Announcements Trials

Browse Landscape

Phase

Status

Completed 119 Unknown 31 Recruiting 31 Terminated 28 Active not recruiting 28 Withdrawn 10 Not yet recruiting 9 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Carcinoma In Situ 1

Interventions

Paclitaxel 4 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Trastuzumab 2 Taxes 2 Tamoxifen 2 Interleukin-2 2 Fluorouracil 2 Cyclophosphamide 2 Anastrozole 2 trastuzumab biosimilar HLX02 1 tivozanib 1 taletrectinib 1 palbociclib 1 fluzoparib 1 exemestane 1 eribulin 1 binimetinib 1 atezolizumab 1 aldesleukin 1 Tomography, Optical Coherence 1 Testosterone Propionate 1 Testosterone 1 Tablets 1 Receptors, Chimeric Antigen 1 Radiotherapy 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × exemestane × Breast × Clear all

NCT06671912 2026-05-08

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡